About
Vaccines & Adjuvants
Areas of Focus
Categories
VaccineMidwest
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
763
By Phase
PHASE1: 4NA: 2
By Status
COMPLETED: 6
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05163847Lead Sponsor
Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults
PHASE1Completed
303 participants
Started: Jun 14, 2022 · Completed: Nov 3, 2022
NCT04785794Lead Sponsor
Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old
PHASE1Completed
122 participants
Started: Jun 30, 2021 · Completed: Nov 30, 2021
NCT03999554Lead Sponsor
Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines
PHASE1Completed
206 participants
Started: Sep 3, 2019 · Completed: Jul 1, 2020
NCT02822105Lead Sponsor
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
PHASE1Completed
96 participants
Started: Jun 30, 2016 · Completed: Nov 30, 2017
NCT01767324Lead Sponsor
Site Selection for Intracutaneous Saline Delivery
NACompleted
12 participants
Started: Dec 31, 2012 · Completed: Dec 31, 2012
Locations (1)
Headquarters
Madison, WI, United States
Map
Loading map...